The content of Tregs is also increased in high TREM-1 group, which could produce immunosuppressive cytokines and immune-inhibitory receptors to disturb the activation of anti-tumor T cell responses, leading to a worse prognosis. This evidence concerns the gene TREM1 and neoplasm.